For use in ENT surgery & epistaxis 1.25cm x 100cm & 2.5cm x 100cm impregnated gauze
Magnesium Sulphate Paste BP
Proflavine Cream, BPC
Collodion Flexible BP
2.5% castor oil & colophony 2.5% in a collodion base.
Skin tissue adhesive
Fibrin sealant (Artiss®)
2ml, 4ml & 10ml prefilled syringe.
For use in plastic surgery to close dead spaces, adhere skin graft, close simple wounds and stabilise bone grafts.
Fibrin sealant (Bioglue®)
For use in neurosurgery and vascular surgery.
Fibrin sealant (Evicel® Human Fibrin Glue)
2ml and 5ml kit
Fibrin sealant (Floseal® Matrix sealant)
Fibrin sealant (Tisseel Lyo® Fibrin Glue)
2ml, 4ml & 10ml kit
Also approved for use in the treatment of mesh fixation in hernia repair.
4.8 & 9.5 cm 2 Haemostatic (collagen sponge coated with fibrinogen and thrombin) - for use in liver and renal surgery.
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Drugs for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician and the drug should be supplied through the hospital throughout the duration of treatment.
In some very exceptional circumstances (e.g. due to distance from the hospital, storage, supply or mobility/transport problems) it may be appropriate for the GP to be asked to prescribe a Red drug. This should be negotiated on an individual patient basis and should only be done with the GP’s prior informed agreement where the roles of the GP and hospital services are clearly defined and agreed. The GP should not feel under pressure to prescribe in these circumstances.
Drugs initiated by hospital specialist, but where continuing treatment by GPs may be appropriate under a shared care arrangement.
The specialist should send the GP a copy of the shared care agreement to sign. The GP should sign the shared care agreement, or indicate they do not want to be part of such an agreement, and return a copy back to the specialist. Shared care guidelines are available or are being developed for most of the drugs listed as Amber.
If no shared care guideline is available, the hospital specialist should provide the patient’s GP with sufficient information and support to allow treatment to be continued and managed safely in primary care.
Drugs normally recommended or initiated by hospital specialist, but where the provision of an information leaflet may be appropriate to facilitate continuing treatment by GPs. Many of these information sheets are in the process of development.
Drugs where prescribing by GPs is appropriate. Drugs not classified as Red, Amber or Green Plus (formerly blue in North of Tyne) are generally classified as ‘Green’ by default. The Green drugs listed here include those products normally initiated by hospital specialists where there was a need for discussion and debate as to the category in which they should be placed.